Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Acta Orthopaedica Scandinavica. Supplementum|June 11, 2004
Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experienceJ O Fernberg, K Sundby HallMedical Oncology (Northwood, London, England)|October 28, 1998
Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancerG R Tennvall, J O FernbergAnti-Cancer Drugs|December 1, 1991
Interaction of melphalan and dexamethasone in a human myeloma cell lineJ O Fernberg, R Lewensohn, S SkogEuropean Journal of Haematology|September 1, 1991
Cell cycle arrest and DNA damage after melphalan treatment of the human myeloma cell line RPMI 8226J O Fernberg, R Lewensohn, S SkogMedical Oncology and Tumor Pharmacotherapy|January 1, 1991
Interphase cell death as related to the cell cycle of melphalan-treated human myeloma cellsJ O Fernberg, R Lewensohn, S SkogEuropean Journal of Cancer & Clinical Oncology|September 1, 1988
Interferon exerts a cytotoxic effect on primary human myeloma cellsS Einhorn, J O Fernberg, D Grandér, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 1990
Oral dosage of melphalan and response to treatment in multiple myelomaJ O Fernberg, B Johansson, R Lewensohn, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitroR Lewensohn, J O Fernberg, H Ehrsson, et al.Medical Oncology (Northwood, London, England)|March 29, 2002
GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapyJ O Fernberg, O Brosjö, S Friesland, et al.Cytokines, Cellular & Molecular Therapy|January 5, 2001
Shrinkage of desmoid tumor with interferon alfa treatment: a case reportL Hardell, M Breivald, S Hennerdal, et al.Pageof 3